Treatment-Resistant Depression

TITUSVILLE, N.J., May 11, 2026 Johnson & Johnson announced the presentation of 18 new and encore abstracts highlighting the...

DUBLIN, Ireland, March 25, 2026 GH Research has announced the peer-reviewed publication of Phase 2b clinical results for GH001...